FDA Documents of Hameln Pharmaceuticals Gmbh
Hameln Pharmaceuticals Gmbh is an organization that has been audited by the FDA 9 times between 2000 and 2016 across all 1 sites.
Documents
FDA 483 Hameln Pharmaceuticals Gmbh, Hameln | 2016
Out-of-stock
Issued on: Jul 1, 2016
Human Drug Form 483
FDA 483 Hameln Pharmaceuticals Gmbh, Hameln | 2014
Out-of-stock
Issued on: Jul 25, 2014
Human Drug Form 483
FDA 483 Hameln Pharmaceuticals Gmbh, Hameln | 2012
Out-of-stock
Issued on: Jun 14, 2012
Human Drug Form 483
FDA 483 Hameln Pharmaceuticals Gmbh, Hameln | 2009
Out-of-stock
Issued on: Nov 9, 2009
Human Drug Form 483
FDA 483 Hameln Pharmaceuticals Gmbh, Hameln | 2007
Out-of-stock
Issued on: May 23, 2007
Human Drug Form 483
FDA 483 Hameln Pharmaceuticals Gmbh, Hameln | 2004
Out-of-stock
Issued on: Jun 24, 2004
Human Drug Form 483
FDA 483 Hameln Pharmaceuticals Gmbh, Hameln | 2000
Out-of-stock
Issued on: Sep 15, 2000
Human Drug Form 483
FDA Investigators(16)
- Dennis Cantellops Paite, FDA Investigator
- Katie L. Penno, FDA Investigator
- Cantellops Paite, Dennis, FDA Investigator
- Nicole A. Lloyd, FDA Investigator
- Michael R. Klapal, FDA Investigator
- Debra M. Emerson, FDA Investigator
- Susan M. Jackson, FDA Investigator
- Simone E. Pitts, FDA Investigator
- Charles L. Larson, FDA Investigator
- Caryn M. McNab, FDA Investigator
- Steven C. Madzo, FDA Investigator
- Raymond T. Oji, FDA Investigator
- Charles I. Ahn, FDA Investigator
- Perry H. Gambrell, FDA Investigator
- Philip F. Istafanos, FDA Investigator
- Barbara M. Frazier, FDA Investigator